Isabel Gudelia Vazquez Gutierrez

Dr. Isabel Gudelia Vazquez Gutierrez

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 June 2024 in ACS Omega
Verified
Journal Article
Open access
IGIsabel Gudelia Vazquez Gutierrez
Isabel Gudelia Vazquez Gutierrez
MRMiguel A. Reyes-López
Miguel A. Reyes-López
SOSara A. Ochoa
Sara A. Ochoa
Ariadnna Cruz-CòrdovaAriadnna Cruz-Còrdova
Ariadnna Cruz-Còrdova
RHRigoberto Hernández-Castro
Rigoberto Hernández-Castro
JXJuan Xicohtencatl-Cortes
Juan Xicohtencatl-Cortes
Urinary tract infections (UTIs) are caused mainly by uropathogenic Escherichia coli (UPEC), accounting for both uncomplicated (75%) and complicated (65%) UTIs. Detecting UPEC in a specific, rapid, and timely manner is essential for eradication, and optical biosensors may be useful tools for detecting UPEC. Recently, biosensors have been developed for the selective detection of antigen–antibody-specific interactions. In this study, a methodology based on the principle of an optical biosensor was developed to identify specific biomolecules, such as the PapG protein, which is located at the tip of P fimbriae and promotes the interaction of UPEC with the uroepithelium of the human kidney during a UTI. For biosensor construction, recombinant PapG protein was generated and polyclonal anti-PapG antibodies were obtained. The biosensor was fabricated in silicon supports because its surface and anchor biomolecules can be modified through its various properties. The fabrication process was carried out using self-assembled monolayers (SAMs) and an immobilized bioreceptor (anti-PapG) to detect the PapG protein. Each stage of biosensor development was evaluated by Fourier transform infrared (FTIR) spectroscopy. The infrared spectra showed bands corresponding to the C–H, CO, and amide II bonds, revealing the presence of the PapG protein. Then, the spectra of the second derivative were obtained from 1600 to 1700 cm–1 to specifically determine the interactions that occur in the secondary structures between the biological recognition element (anti-PapG antibodies) and the analyte (PapG protein) complex. The analyzed secondary structure showed β-sheets and β-turns during the detection of the PapG protein. Our data suggest that the PapG protein can be detected through an optical biosensor and that the biosensor exhibited high specificity for the detection of UPEC strains. Furthermore, these studies provide initial support for the development of more specific biosensors that can be applied in the future for the detection of clinical UPEC samples associated with ITUs.

15 November 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
SOSara A. Ochoa
Sara A. Ochoa
IGIsabel Gudelia Vazquez Gutierrez
Isabel Gudelia Vazquez Gutierrez
MFMarco Antonio Antonio Flores-Oropeza
Marco Antonio Antonio Flores-Oropeza
RHRigoberto Hernandez-Castro
Rigoberto Hernandez-Castro
JAJosé Arellano-Galindo
José Arellano-Galindo
JXJuan Xicohtencatl-Cortes
Juan Xicohtencatl-Cortes
Urinary tract infections (UTIs) are a major global health care challenge, and uropathogenic Escherichia coli (UPEC) is the primary etiological agent. The emergence of multidrug-resistant UPEC strains increasingly compromises therapeutic management, highlighting the need for novel prophylactic strategies. However, UPEC exhibits high fimbrial diversity and can upregulate alternative chaperone–usher systems to maintain adherence when a single colonization pathway is disrupted. To overcome this adaptive pathogenicity, we evaluated the immunogenicity and functional efficacy of three engineered trimeric fusion proteins that differ in their topological orientation: designated PFC, FCP, and CPF. They comprise the key surface adhesins FimH, CsgA, and PapG. A stratified cross-sectional analysis was conducted using 62 pediatric UPEC clinical strains to determine their phylogenetic groups and fimbrial genotypes through multiplex PCR. In patient cohorts, local (urine, n = 62) and systemic (serum, n = 16 per group) antibody profiles against the recombinant antigens were quantified through indirect ELISA. The functional blocking capacity of hyperimmune rabbit polyclonal antibodies was assessed through in vitro adherence inhibition assays with HTB-5 bladder epithelial cells infected with the reference strain CFT073. Genomic characterization revealed 100% prevalence of the individual core colonization factors fimH and csgA across strains. However, PCR-based detection of these loci offers only theoretical gene-target coverage within this sample collection without establishing active in vivo antigen expression or functional surface accessibility during infection. Genotypically, the baseline core target combination (fimH + csgA + papG-) was present in 58.1% (36/62) of the total cohort, whereas the complex virulence genotype fimH + csgA + papGII was identified in 40.3% (25/62) of the strains and showed strict tropism for the extraintestinal phylogroups B2 and D, which represented 42% (26/62) and 38% (24/62) of the overall population, respectively. Within phylogroup D, the (papAH) structural gene was detected in 29.2% (7/24) of its strains. This specific subset of seven strains positive for the (fimH + csgA + papGII) genotype within phylogroup D accounted for 11.3% of the total 62 clinical isolates analyzed, highlighting its epidemiological significance in severe pediatric infections. In patients with active UPEC infection, a robust humoral response was observed compared with that in healthy controls, as demonstrated by significantly elevated urinary IgG and IgA titers (p < 0.0001). Serum analysis demonstrated that the PFC chimera effectively distinguished UPEC-induced UTIs from UTIs induced by other uropathogens, revealing significantly higher IgA (p = 0.0008) and IgG (p < 0.0001) levels, thereby establishing its potential value as a systemic diagnostic immunogenic antigen target platform. Crucially, functional cell-adherence assays revealed that α-PFC antibodies produced the greatest reduction in bacterial attachment, limiting residual colonization to 22.7% (p < 0.0001). This optimized configuration significantly outperformed alternative structural chimeric configurations (α-FCP, p = 0.0011; α-CPF, p = 0.0008), suggesting that the specific PFC topological orientation may minimize steric hindrance between receptor-binding loops during multifimbrial interactions. The engineered PFC trimeric protein is a structurally optimized antigen platform with potential for future broad-spectrum prophylactic strategies against recurrent UTIs ; however, its in vivo immunogenicity, protective clearance, and cross-strain efficacy remain to be determined.